KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $155.0 million.

  • Colgate Palmolive's Capital Expenditures rose 1567.16% to $155.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.0 million, marking a year-over-year decrease of 52.26%. This contributed to the annual value of $561.0 million for FY2024, which is 2042.55% down from last year.
  • Colgate Palmolive's Capital Expenditures amounted to $155.0 million in Q3 2025, which was up 1567.16% from $108.0 million recorded in Q2 2025.
  • Colgate Palmolive's Capital Expenditures' 5-year high stood at $221.0 million during Q4 2022, with a 5-year trough of $107.0 million in Q1 2021.
  • In the last 5 years, Colgate Palmolive's Capital Expenditures had a median value of $155.0 million in 2025 and averaged $153.5 million.
  • In the last 5 years, Colgate Palmolive's Capital Expenditures skyrocketed by 6883.12% in 2021 and then crashed by 3641.3% in 2024.
  • Quarter analysis of 5 years shows Colgate Palmolive's Capital Expenditures stood at $193.0 million in 2021, then increased by 14.51% to $221.0 million in 2022, then dropped by 10.86% to $197.0 million in 2023, then fell by 6.6% to $184.0 million in 2024, then dropped by 15.76% to $155.0 million in 2025.
  • Its last three reported values are $155.0 million in Q3 2025, $108.0 million for Q2 2025, and $124.0 million during Q1 2025.